PPARD and neoplasm: The selective PPARδ agonist GW501516 acts as a tumor promoter in mammary carcinogenesis [19] and colon tumorigenesis [15, 20, 21], whereas disruption of PPARδ expression blocks mammary [22] and colon tumorigenesis [23, 24].